KeyBanc Keeps Their Buy Rating on Healthequity

In a report released today, Donald Hooker from KeyBanc maintained a Buy rating on Healthequity (NASDAQ: HQY), with a price target of $82. The company’s shares closed yesterday at $76.36, close to its 52-week high of $78.10.

Hooker has an average return of 25.2% when recommending Healthequity.

According to TipRanks.com, Hooker is ranked #367 out of 4819 analysts.

Currently, the analyst consensus on Healthequity is Strong Buy and the average price target is $72.88, representing a -4.6% downside.

In a report issued on May 23, Merrill Lynch also initiated coverage with a Buy rating on the stock with a $83 price target.

See today’s analyst top recommended stocks >>

Healthequity’s market cap is currently $4.64B and has a P/E ratio of 100.47. The company has a Price to Book ratio of 13.41.

Based on the recent corporate insider activity of 104 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. engages in the provision of healthcare saving solutions. Its products include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.